Skip to content

Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)

Self-Guided Resilience-Building Energy Management to Enhance Well-being Intervention for People With Systemic Sclerosis: A Feasibility Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07402863
Acronym
RENEW
Enrollment
43
Registered
2026-02-11
Start date
2025-01-28
Completion date
2025-07-28
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

Brief summary

The goal of this clinical trial is to gather information on the RENEW app used by people with scleroderma. Specifically, the researchers want to learn more about RENEW by collecting information about the rates of recruitment, retention of study participants information about study completion, and time spent accessing the app content.

Detailed description

RENEW is Institutional Review Board approved as a non-significant risk device but it not subject to 510(k) and therefore not regulated by the FDA.

Interventions

DEVICERENEW

The RENEW program is 12-week program where participants are asked to access the app and set and track weekly healthy goals.

Sponsors

University of Michigan
Lead SponsorOTHER
Shepherd Center, Atlanta GA
CollaboratorOTHER
National Institute on Disability, Independent Living, and Rehabilitation Research
CollaboratorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have a diagnosis of systemic sclerosis including: diffuse cutaneous SSc, limited cutaneous SSc, overlap, or SINE * Have access to a reliable, internet-connected device (e.g. smartphone or tablet) * Be able to read, speak, and understand English * Participants need to report a score of at least 4 on a scale of 0 - 10 of fatigue severity, a cut-off for at least moderate fatigue in other fatiguing conditions1

Exclusion criteria

* Complex, unstable health issues that would preclude full participation in the study * Planning to start new treatment for fatigue, pain, mood during the study period * Previous experience with RENEW app or past participant of RENEW

Design outcomes

Primary

MeasureTime frameDescription
Feasibility based on study recruitment rate12 weeksNumber of participants enrolled (over 3 months) divided by the number of individuals who were eligible to participate
Feasibility based on study retention12 weeksNumber of participants who complete the study

Secondary

MeasureTime frameDescription
RENEW participation - website12 weeksReported as the number of minutes spent accessing the RENEW app
Acceptability12 weeksAssessed using the 12-week feedback questionnaire

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSusan Murphy, ScD, OTR

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026